Metropolitan Life Insurance Company (MetLife)’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,583
Closed -$879K 1023
2024
Q1
$879K Sell
6,583
-61
-0.9% -$8.18K 0.04% 360
2023
Q4
$900K Sell
6,644
-88
-1% -$10.2K 0.04% 337
2023
Q3
$899K Sell
6,732
-351
-5% -$57.7K 0.05% 320
2023
Q2
$1.29M Sell
7,083
-150
-2% -$30.4K 0.06% 275
2023
Q1
$1.64M Sell
7,233
-2,121
-23% -$434K 0.08% 223
2022
Q4
$1.84M Sell
9,354
-94
-1% -$19.5K 0.08% 238
2022
Q3
$1.75M Sell
9,448
-113
-1% -$22.4K 0.08% 239
2022
Q2
$1.71M Sell
9,561
-189
-2% -$48.3K 0.08% 250
2022
Q1
$3.31M Sell
9,750
-15,233
-61% -$5.15M 0.12% 162
2021
Q4
$9.25M Buy
24,983
+346
+1% +$131K 0.13% 127
2021
Q3
$9.72M Sell
24,637
-742
-3% -$341K 0.14% 116
2021
Q2
$11.7M Sell
25,379
-905
-3% -$364K 0.16% 101
2021
Q1
$9.82M Sell
26,284
-1,531
-6% -$624K 0.15% 113
2020
Q4
$10M Sell
27,815
-1,082
-4% -$345K 0.15% 114
2020
Q3
$8.69M Sell
28,897
-1,290
-4% -$444K 0.15% 122
2020
Q2
$10.9M Buy
30,187
+659
+2% +$212K 0.19% 92
2020
Q1
$7.85M Sell
29,528
-421
-1% -$118K 0.16% 113
2019
Q4
$9.66M Buy
29,949
+12
+0% +$3.64K 0.15% 118
2019
Q3
$8.86M Buy
29,937
+74
+0.2% +$21.8K 0.15% 119
2019
Q2
$10.7M Buy
29,863
+1,521
+5% +$480K 0.18% 96
2019
Q1
$8.57M Sell
28,342
-1,100
-4% -$321K 0.16% 114
2018
Q4
$8.59M Sell
29,442
-136
-0.5% -$42.1K 0.17% 99
2018
Q3
$10.6M Sell
29,578
-684
-2% -$219K 0.18% 97
2018
Q2
$8.22M Buy
30,262
+311
+1% +$79.1K 0.13% 137
2018
Q1
$6.89M Buy
29,951
+261
+0.9% +$59.8K 0.1% 166
2017
Q4
$6.31M Sell
29,690
-48,061
-62% -$9.89M 0.08% 179
2017
Q3
$15.1M Sell
77,751
-1,100
-1% -$205K 0.09% 193
2017
Q2
$13.3M Sell
78,851
-1,492
-2% -$258K 0.09% 201
2017
Q1
$13.3M Sell
80,343
-1,413
-2% -$223K 0.09% 210
2016
Q4
$10.2M Sell
81,756
-1,862
-2% -$251K 0.07% 253
2016
Q3
$14.8M Sell
83,618
-1,340
-2% -$214K 0.11% 179
2016
Q2
$11.6M Sell
84,958
-528
-0.6% -$75K 0.09% 225
2016
Q1
$13.5M Sell
85,486
-846
-1% -$129K 0.1% 180
2015
Q4
$16.1M Buy
86,332
+75,525
+699% +$12.2M 0.12% 158
2015
Q3
$1.85M Hold
10,807
0.01% 935
2015
Q2
$2.3M Buy
10,807
+707
+7% +$138K 0.02% 916
2015
Q1
$1.82M Hold
10,100
0.01% 922
2014
Q4
$1.81M Buy
10,100
+268
+3% +$47.2K 0.01% 1006
2014
Q3
$1.57M Buy
9,832
+708
+8% +$118K 0.01% 1036
2014
Q2
$1.58M Buy
9,124
+328
+4% +$48.9K 0.01% 1096
2014
Q1
$1.27M Hold
8,796
0.01% 1184
2013
Q4
$946K Hold
8,796
0.01% 1367
2013
Q3
$692K Sell
8,796
-118
-1% -$9.03K 0.01% 1534
2013
Q2
$649K Buy
+8,914
New +$571K 0.01% 1520

Other funds holding ILMN

Metropolitan Life Insurance Company (MetLife)'s ILMN Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Illumina (ILMN) in Q2 2024, closing a stake of 6,583 shares — an estimated $879K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ILMN in Q2 2013 and held it in 44 quarters. The position peaked at $16.1M in Q4 2015. 774 funds tracked by Wall St. Rank hold ILMN as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Illumina position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,583 Illumina shares in Q2 2024, an estimated $879K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Illumina in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Illumina position peaked at $16.1M in Q4 2015.
  • 774 funds tracked by Wall St. Rank held Illumina as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.